Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Phase 3 Completed 127 enrolled Ferring Pharmaceuticals Ferring Pharmaceuticals Korea, Ltd. · collab

NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, multi-centre single arm trial to investigate long-term safety and tolerability of degarelix in Korean patients with prostate cancer.

Timeline

Start: 2010-09
Primary completion: 2012-04
Completion: 2012-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Degarelix	Other / unclassified	—	—

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Summary

Timeline

Drugs

Indications